BHVN today
$14.35-$0.84 (-5.53%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourLeaning Bearish
1 hourBearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns down below $10.70
Key levels
Resistance$16.49
Resistance$14.97
Support$13.76
Support$12.27
Latest news & SEC filings
ProductBiohaven reports progress in its Graves' disease program
AnalystMorgan Stanley keeps Biohaven at Overweight, lifts target to $21
AnalystMorgan Stanley keeps Overweight on Biohaven, lifts target to $21
All BHVN news →About Biohaven
This company develops medicines in the areas of immune system disorders, brain and nervous system conditions, and cancer. Its pipeline features treatments aimed at potassium channel targets for seizures, protein-degrading molecules for autoimmune diseases, and a muscle-growth pathway therapy for conditions affecting muscles and metabolism. It holds rights to nearly all of its candidates and conducts operations globally.
Based on the company's 10-K filed Mar 2, 2026.
NYSE · Healthcare
Biohaven Ltd. (BHVN)
What Is the Price Target for BHVN?
SEPT Low Target
$11.00
SEPT Mid Target
$21.00
SEPT High Target
$32.00
Analyst Consensus
$21.00
Is BHVN a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BHVN.
Start Free Trial →Is BHVN Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$21.00
0
Moat Score
NONE
1/9
Piotroski Score
-8.8
Altman Z-Score
What Is Smart Money Doing with BHVN?
Insider Signal
NEUTRAL
1 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BHVN Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
26.08%
FCF Growth YoY
-4.0%
Revenue Trend
UNKNOWN
Dark Pool Trades for BHVN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BHVN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:27:37 | $14.37 | 2,012 | $$29K | SELL |
| 16:29:01 | $14.55 | 3,026 | $$44K | SELL |
| 15:58:20 | $14.68 | 2,500 | $$37K | BUY |
| 15:32:38 | $14.46 | 1,000 | $$14K | SELL |
| 15:27:19 | $14.38 | 1,000 | $$14K | MIDPOINT |
5 dark pool trades shown · $$138K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for BHVN
PREVIEWSEPT Investing provides real-time options flow tracking for BHVN, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $15 | Dec 18 | 36 | $$190 | 1 | SWEEP |
| PUT | $15 | Dec 18 | 36 | $$190 | 1 | SWEEP |
| PUT | $15 | Dec 18 | 36 | $$190 | 1 | SWEEP |
| PUT | $15 | Dec 18 | 36 | $$190 | 1 | SWEEP |
| PUT | $15 | Dec 18 | 36 | $$190 | 1 | SWEEP |
5 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About BHVN
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for BHVN. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
SEPT Brain on $BHVN -- Neutral BHVN at $15.05. Day range $14.69-$15.74. Last candle: shooting star (1% buying). Price in middle of zone $13.40-$16.00 — direction unclear, stop too wide. Wait for pric...
Join 3,500+ traders discussing BHVN in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Biohaven Ltd. (BHVN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BHVN — frequently asked questions
What is BHVN stock price today?
Biohaven Ltd. (BHVN) is at $14.35, down 5.53% (-$0.84) at the Nov 12, 2026 close.
Why is BHVN stock moving today?
Latest BHVN news — Nov 5, 2026: Biohaven reports progress in its Graves' disease program · Nov 3, 2026: Morgan Stanley keeps Biohaven at Overweight, lifts target to $21
What is the BHVN price target?
The average analyst price target for BHVN is $21.00, ranging from $11 to $32, based on 7 analysts. Latest: Morgan Stanley maintains on Nov 3, 2026.
What do analysts rate BHVN?
Analyst ratings for BHVN: 0 Buy, 11 Hold, 2 Sell — consensus Hold.
Did BHVN beat earnings?
BHVN last reported on Oct 29, 2026: EPS -$0.86 vs -$0.78 expected — a miss of 9.8%.
Does BHVN pay a dividend?
BHVN does not currently pay a dividend.
What are BHVN support and resistance levels?
Support: $13.76, $12.27, $10.70. Resistance: $14.97, $16.49, $18.24.
What are insiders doing with BHVN?
Insider activity: NEUTRAL, 1 buys and 0 sells in the last 90 days.
What is the latest news on BHVN?
Nov 5, 2026: Biohaven reports progress in its Graves' disease program · Nov 3, 2026: Morgan Stanley keeps Biohaven at Overweight, lifts target to $21 · Nov 3, 2026: Morgan Stanley keeps Overweight on Biohaven, lifts target to $21